PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION

被引：70

作者：

BERG, SL ^{[1
]}

COWAN, KH ^{[1
]}

BALIS, FM ^{[1
]}

FISHERMAN, JS ^{[1
]}

DENICOFF, AM ^{[1
]}

HILLIG, M ^{[1
]}

POPLACK, DG ^{[1
]}

OSHAUGHNESSY, JA ^{[1
]}

机构：

[1] NCI,MED BRANCH,BETHESDA,MD 20892

来源：

关键词：

D O I：

10.1093/jnci/86.2.143

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：143 / 145

页数：3

共 20 条

[1] A PHASE-I TRIAL OF TAXOL GIVEN BY A 6-HOUR INTRAVENOUS-INFUSION
BROWN, T
HAVLIN, K
WEISS, G
CAGNOLA, J
KOELLER, J
KUHN, J
RIZZO, J
CRAIG, J
PHILLIPS, J
VONHOFF, D
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (07) : 1261 - 1267
[2] BUGAT R, 1989, EUR J CANCER CLIN ON, V25, P503
[3] DESSYPYRIS EN, 1984, P AM ASSOC CANC RES, V25, P1203
[4] ESTIMATION OF DOXORUBICIN AND DOXORUBICINOL BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND ADVANCED AUTOMATED SAMPLE PROCESSOR
DOBBS, NA
JAMES, CA
[J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 420 (01): : 184 - 188
[5] FISHERMAN J, IN PRESS MONOGR NATL
[6] GREENE RF, 1983, CANCER RES, V43, P3417
[7] HAHN S, 1992, 2ND NAT CANC I WORKS
[8] HOLMES FA, 1992, P AN M AM SOC CLIN, V11, P60
[9] JAMISDOW CA, 1992, 2ND NAT CANC I WORKS
[10] LONGNECKER SM, 1987, CANCER TREAT REP, V71, P53